tradingkey.logo

Waters Corp

WAT
349.600USD
+6.700+1.95%
Close 10/31, 16:00ETQuotes delayed by 15 min
20.81BMarket Cap
31.46P/E TTM

Waters Corp

349.600
+6.700+1.95%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Waters Corp

Currency: USD Updated: 2025-10-31

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Waters Corp's Score

Industry at a Glance

Industry Ranking
18 / 210
Overall Ranking
87 / 4618
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 17 analysts
Buy
Current Rating
360.550
Target Price
+5.15%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Waters Corp Highlights

StrengthsRisks
Waters Corporation offers analytical instruments and software across chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. Its segments include Waters and TA. The Waters segment is primarily in the business of designing, manufacturing, selling and servicing liquid chromatography (LC) and MS instrument systems, columns and other precision chemistry consumables that can be integrated and used along with other analytical instruments. The TA segment is primarily in the business of designing, manufacturing, selling and servicing thermal analysis, rheometry and calorimetry instruments.
Fairly Valued
The company’s latest PE is 31.40, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 59.15M shares, decreasing 0.82% quarter-over-quarter.
Held by Invesco
Star Investor Invesco holds 879.78K shares of this stock.

Financial Health

Currency: USD Updated: 2025-10-31

The company's current financial score is 7.36, which is lower than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 771.33M, representing a year-over-year increase of 8.86%, while its net profit experienced a year-over-year increase of 3.06%.

Score

Industry at a Glance

Previous score
7.36
Change
0

Financials

9.59

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data

Quality of Earnings

5.93

Operational Efficiency

6.73

Growth Potential

7.93

Shareholder Returns

6.62

Waters Corp's Company Valuation

Currency: USD Updated: 2025-10-31

The company’s current valuation score is 6.79, which is lower than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is 31.40, which is 23.61% below the recent high of 38.82 and 31.65% above the recent low of 21.46.

Score

Industry at a Glance

Previous score
6.79
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 18/210
No Data

Earnings Forecast

Currency: USD Updated: 2025-10-31

The company’s current earnings forecast score is 7.22, which is lower than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Waters Corp is 350.00, with a high of 460.00 and a low of 315.00.

Score

Industry at a Glance

Previous score
7.22
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 17 analysts
Buy
Current Rating
360.550
Target Price
+5.15%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

89
Total
4
Median
7
Average
Company name
Ratings
Analysts
Waters Corp
WAT
17
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
35
Intuitive Surgical Inc
ISRG
34
Veeva Systems Inc
VEEV
33
Thermo Fisher Scientific Inc
TMO
30
1
2
3
...
18

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-31

The company’s current price momentum score is 8.94, which is higher than the Healthcare Equipment & Supplies industry's average of 6.65. Sideways: Currently, the stock price is trading between the resistance level at 370.35 and the support level at 323.50, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
7.39
Change
1.55

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(3)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
-1.575
Neutral
RSI(14)
63.017
Neutral
STOCH(KDJ)(9,3,3)
39.134
Sell
ATR(14)
9.898
High Vlolatility
CCI(14)
23.789
Neutral
Williams %R
37.058
Buy
TRIX(12,20)
0.536
Sell
StochRSI(14)
50.407
Buy
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
346.734
Buy
MA10
348.993
Buy
MA20
339.817
Buy
MA50
316.545
Buy
MA100
315.835
Buy
MA200
340.871
Buy

Institutional Confidence

Currency: USD Updated: 2025-10-31

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.43. The latest institutional shareholding proportion is 99.37%, representing a quarter-over-quarter increase of 2.39%. The largest institutional shareholder is The Vanguard, holding a total of 7.38M shares, representing 12.40% of shares outstanding, with 4.14% increase in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
The Vanguard Group, Inc.
Star Investors
7.38M
+1.89%
AllianceBernstein L.P.
4.02M
+30.96%
BlackRock Institutional Trust Company, N.A.
3.81M
-1.24%
Fundsmith LLP
3.61M
-0.13%
State Street Investment Management (US)
2.68M
+1.43%
MFS Investment Management
1.77M
-10.04%
Geode Capital Management, L.L.C.
1.55M
+2.79%
Fundsmith Investment Services Ltd.
1.22M
+0.41%
Walter Scott & Partners Ltd.
1.14M
-1.55%
Janus Henderson Investors
906.48K
+0.55%
1
2

Risk Assessment

Currency: USD Updated: 2025-10-31

The company’s current risk assessment score is 8.46, which is higher than the Healthcare Equipment & Supplies industry's average of 4.56. The company's beta value is 1.12. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
8.46
Change
0
Beta vs S&P 500 index
1.12
VaR
+3.04%
240-Day Maximum Drawdown
+33.45%
240-Day Volatility
+38.02%

Return

Best Daily Return
60 days
+6.67%
120 days
+6.67%
5 years
+19.84%
Worst Daily Return
60 days
-2.86%
120 days
-13.81%
5 years
-13.81%
Sharpe Ratio
60 days
+3.20
120 days
+0.28
5 years
+0.33

Risk Assessment

Maximum Drawdown
240 days
+33.45%
3 years
+33.45%
5 years
+44.27%
Return-to-Drawdown Ratio
240 days
-0.22
3 years
+0.03
5 years
+0.13
Skewness
240 days
-0.66
3 years
+0.74
5 years
+0.60

Volatility

Realised Volatility
240 days
+38.02%
5 years
+32.93%
Standardised True Range
240 days
+3.20%
5 years
+2.57%
Downside Risk-Adjusted Return
120 days
+34.05%
240 days
+34.05%
Maximum Daily Upside Volatility
60 days
+25.90%
Maximum Daily Downside Volatility
60 days
+16.55%

Liquidity

Average Turnover Rate
60 days
+1.31%
120 days
+1.12%
5 years
--
Turnover Deviation
20 days
+38.79%
60 days
+51.75%
120 days
+29.38%

Peer Comparison

Healthcare Equipment & Supplies
Waters Corp
Waters Corp
WAT
7.94 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
Cencora Inc
COR
8.56 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Boston Scientific Corp
Boston Scientific Corp
BSX
8.51 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
Artivion Inc
AORT
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Castle Biosciences Inc
Castle Biosciences Inc
CSTL
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Hologic Inc
Hologic Inc
HOLX
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI